Novo Nordisk A/S
ANTIBODIES AND USE THEREOF

Last updated:

Abstract:

The present invention relates to specific antibodies and use thereof, such as for identifying and/or quantifying liraglutide fibrils and/or semaglutide fibrils.

Status:
Application
Type:

Utility

Filling date:

19 Nov 2021

Issue date:

3 Mar 2022